bodyType

customContents

entityId

entityUuid

articlePageQuery

filter

article

articleBaseAdvertisingInfoArticle

articleListArticle

articleSeoArticle

helpersCheckIsPostiesArticle

hooksArticleAcknowledgementGateOverlayArticle

hooksTrackPageViewArticle

hooksContentInterestArticle

articleLinkingDataContent

articleSchemaContent

liveArticle

advertZone

sentiment

contentLock

topics

types

sections

moreOnThisArticles

urlAlias

commentCount

sponsorType

authorLocations

authors

paywallTypes

corrections

displaySlideShow

multimediaEmbed

printHeadline

seriesContainer

socialHeadline

headline

flag

firstTopic

glossary

flattenTypeIds

publishedDate

additionalInfoBoxes

images

image

relatedLinks

relatedNewsletters

__typename

createdDate

sponsor

factSheets

series

knowledgeQuestion

disableOffPlatformContent

published

updatedDate

summary

subHeadline

body

keywords

copyrighted

customTimezone

liveContents

Mary Ann

Mary Ann Benitez

A Hong Kong company has developed a new surgical mask, which it claims can kill germs while  being  comfortable  to wear all day.
But experts say more research should be done on how well the masks perform in protecting against flu and other diseases, especially as stockpiling of masks is part of pandemic preparedness in Hong Kong.
The BioMask,  made by Sheung Wan-based  Filligent Ltd,  has an active chemical material that binds to viruses and bacteria, killing them.
The germs target sialic acid receptors  - a kind of molecule - outside human cells and  Hong Kong scientists  applied this chemical mechanism to make a mask with 'intelligent filtration'.
Benjamin Cowling,  an assistant professor of community medicine at University of Hong Kong,  said the new mask was 'an exciting idea'. 
But he  added: 'There should be more research on how well these masks perform against transmission of lots of different diseases, whether compared to other surgical masks or compared to not wearing masks.'
Dr Cowling saw the mask when it was launched at last week's virology conference in Hong Kong.
A study by an Australian team, the results of which were revealed at the same conference, found masks made little difference in the spread of flu-like illnesses in households. 
'Household use of masks is associated with low adherence and is ineffective in controlling seasonal respiratory diseases,' the study of 286 exposed adults in 143 households found.
Dr Cowling said wearing masks would help at the start of a pandemic, when vaccines and antivirals  would be limited to those countries that  could manufacture or  afford to buy them.
'I also find it relevant for regular year-to-year influenza if we find these interventions can really prevent transmissions,' he said.
Paul Chan Kay-sheung,  a flu virologist and professor at Chinese University,  said the jury was still out on whether surgical masks reduced the spread of flu.
'Most data currently suggest surgical masks are not effective when used in the general population. But N95 masks have been found to be effective in hospital settings,' he said. 
The N95  is the mask recommended for infection prevention by the World Health Organisation and the US Centres for Disease Control. 
'There is a need to develop new masks because current masks, like the N95, are not comfortable at all. If you want good compliance with wearing masks, there should be further development of the masks,' Professor Chan said.
He said it would be interesting to see whether the use of advanced technology in surgical masks would improve safety and compliance.
Melissa Mowbray-D'Arbela, the  chairwoman and founder of Filligent,  said the company's mask was more cost-effective. 
'The beauty of this is you don't need to replace it. Because it is self-sanitising, you can wear it the whole day,' she said. 'With N95 you have to replace it about 6-8 times a day.'
Ralf Altmeyer,  a virologist and senior consultant for infectious diseases at Filligent, said: 'The current masks work with mechanical filtration so the filter needs to be very tight in order to filter well. The tighter the filter is, the more difficult it is to breathe and the hotter it gets, and the wearer can't wear it for a long time.'
The BioMask gained certification from the European Community on February 13 and is awaiting US Food and Drug Administration approval.



Firm develops new mask to guard against disease